Delivery Order SPE2DX22D0010-SPE2D826FAP25
- Not listed
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg, with a ceiling value of $3,780.69. The contract is a firm fixed price delivery order with an ultimate completion date of October 7, 2025, awarded on October 6, 2025. No set-aside designation was applied to this award, indicating it was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg with a ceiling value of $4,271.13. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,866.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25mg. The contract was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This was a competitive award with no set-aside designation. This delivery order represents a child contract under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,125.17 on October 20, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules, 30mg, with completion expected by October 21, 2025. This competitively awarded, firm fixed price contract was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain. The award represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of Amphetamine Mix (AD) Extended Release Capsules, 20mg, with a potential value of $1,271.37 and a completion date of January 11, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Amphetamine Mix extended-release capsules at 37.5 mg dosage strength. This competitive delivery order, valued at $1,094.39, represents a firm fixed-price procurement with an ultimate completion date of August 14, 2025. The contract is classified as a child award, indicating it derives from a larger indefinite delivery contract vehicle. Performance of...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Amphetamine Mix Extended-Release Capsules 25mg, with a ceiling value of $1,161.88 and an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,447.49 firm fixed-price contract is for the delivery of Amphetamine Mix (AD) Extended Release Capsules, 15mg. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,267.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 5MG, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was issued to AmerisourceBergen's Corporate Office division, with performance taking place at the contractor's facility in Conshohocken,...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAP25Delivery Order
The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg, with a ceiling value of $2,137.71. This competitively awarded, firm fixed-price delivery order was executed on October 23, 2025, with an ultimate completion date of October 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. No set-aside designation was applied to this procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.99 million and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal medical vendor supplying a broad portfolio of medications and medical supplies to military healthcare systems, the Defense Health Agency, and other government healthcare entities. The company's federal contract awards demonstrate consistent capability in fulfilling diverse pharmaceutical procurement requirements through open competition, ranging from small-value transactions to substantial medical supply orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/23/25 |